Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators by Prescott, Joseph et al.
Rousette Bat Dendritic Cells Overcome Marburg Virus-
Mediated Antiviral Responses by Upregulation of Interferon-
Related Genes While Downregulating Proinflammatory Disease
Mediators
Joseph Prescott,a,b Jonathan C. Guito,b Jessica R. Spengler,b Catherine E. Arnold,c Amy J. Schuh,b Brian R. Amman,b
Tara K. Sealy,b Lisa W. Guerrero,b Gustavo F. Palacios,d Mariano Sanchez-Lockhart,d,e Cesar G. Albariño,b Jonathan S. Townerb
aCenter for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany
bViral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
cDiagnostic Systems Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
dCenter for Genome Sciences, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
eDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
ABSTRACT Dysregulated and maladaptive immune responses are at the forefront
of human diseases caused by infection with zoonotic viral hemorrhagic fever viruses.
Elucidating mechanisms of how the natural animal reservoirs of these viruses coexist
with these agents without overt disease, while permitting sufficient replication to al-
low for transmission and maintenance in a population, is important for understand-
ing the viral ecology and spillover to humans. The Egyptian rousette bat (ERB) has
been identified as a reservoir for Marburg virus (MARV), a filovirus and the etiologi-
cal agent of the highly lethal Marburg virus disease. Little is known regarding how
these bats immunologically respond to MARV infection. In humans, macrophages
and dendritic cells (DCs) are primary targets of infection, and their dysregulation is
thought to play a central role in filovirus diseases, by disturbing their normal func-
tions as innate sensors and adaptive immune response facilitators while serving as
amplification and dissemination agents for the virus. The infection status and re-
sponses to MARV in bat myeloid-lineage cells are uncharacterized and likely repre-
sent an important modulator of the bat’s immune response to MARV infection. Here,
we generate DCs from the bone marrow of rousette bats. Infection with a bat iso-
late of MARV resulted in a low level of transcription in these cells and significantly
downregulated DC maturation and adaptive immune-stimulatory pathways while si-
multaneously upregulating interferon-related pathogen-sensing pathways. This study
provides a first insight into how the bat immune response is directed toward pre-
venting aberrant inflammatory responses while mounting an antiviral response to
defend against MARV infection.
IMPORTANCE Marburg viruses (MARVs) cause severe human disease resulting from
aberrant immune responses. Dendritic cells (DCs) are primary targets of infection
and are dysregulated by MARV. Dysregulation of DCs facilitates MARV replication
and virus dissemination and influences downstream immune responses that result in
immunopathology. Egyptian rousette bats (ERBs) are natural reservoirs of MARV, and
infection results in virus replication and shedding, with asymptomatic control of the
virus within weeks. The mechanisms that bats employ to appropriately respond to
infection while avoiding disease are unknown. Because DC infection and modulation
are important early events in human disease, we measured the transcriptional re-
sponses of ERB DCs to MARV. The significance of this work is in identifying cell type-
specific coevolved responses between ERBs and MARV, which gives insight into how
Citation Prescott J, Guito JC, Spengler JR,
Arnold CE, Schuh AJ, Amman BR, Sealy TK,
Guerrero LW, Palacios GF, Sanchez-Lockhart M,
Albariño CG, Towner JS. 2019. Rousette bat
dendritic cells overcome Marburg virus-
mediated antiviral responses by upregulation
of interferon-related genes while
downregulating proinflammatory disease
mediators. mSphere 4:e00728-19. https://doi
.org/10.1128/mSphere.00728-19.
Editor W. Paul Duprex, University of Pittsburgh
School of Medicine
This is a work of the U.S. Government and is
not subject to copyright protection in the
United States. Foreign copyrights may apply.
Address correspondence to Joseph Prescott,
prescottj@rki.de, or Jonathan S. Towner,
jit8@cdc.gov.
Received 4 October 2019




November/December 2019 Volume 4 Issue 6 e00728-19 msphere.asm.org 1
4 December 2019
 on A








bat reservoirs are able to harbor MARV and permit viral replication, allowing trans-
mission and maintenance in the population while simultaneously preventing immu-
nopathogenesis.
KEYWORDS Ebola virus, Marburg virus, immune response, rousette bat, viral
hemorrhagic fever, virology
Egyptian rousette bats (ERBs) (Rousettus aegyptiacus) have been identified as anatural reservoir of Marburg virus (MARV) and Ravn virus (RAVV), collectively called
marburgviruses. Furthermore, there is increasing evidence that ebolaviruses, including
Ebola virus (EBOV), also in the family Filoviridae, are hosted by various species of bats
(1–5). These filoviruses have caused numerous outbreaks across Africa, including the
2013–2016 Western African EBOV outbreak that resulted in over 11,000 deaths (6,
7). Following the discovery of MARV in 1967, almost 500 cases of MARV disease
(MVD) have been recorded, with an overall case fatality rate of 80%. Since 2007, all
outbreaks of MVD have occurred in Uganda, where ecological studies designed to
identify the origin of human cases consistently pinpointed the ERB as a reservoir
based on the repeated isolation of genetically diverse MARVs and RAVVs directly
from ERBs (3, 8).
The human disease caused by pathogenic filoviruses is complex and involves
multiple physiological pathways that ultimately result in coagulopathy and fluid leak-
age (9). Far more is known regarding EBOV disease (EVD) than MVD; however, the
pathogenic processes are likely similar between the two virus genera (10). Central to
filovirus disease is dysregulation of the immune system. These viruses target and
replicate in dendritic cells (DCs) and monocytes/macrophages (9). DCs are the most
important antigen-presenting cells and are central to innate immunity as well as
directing subsequent adaptive immune responses (11). Upon sensing microbes, DCs
simultaneously mature and traffic to secondary lymph tissue and stimulate T cells
(12). The interaction of DCs and cells of the adaptive immune system dictates the
quality and magnitude of the immune response generated. Human monocyte-
derived DCs (MDDCs) fail to secrete cytokines and display an impaired maturation
and activation phenotype in response to MARV infection (13), and interferon
(IFN)-related antiviral responses are actively antagonized by viral proteins (14).
Conversely, monocytes and macrophages, which are also permissive for infection,
respond to MARV by strong upregulation of proinflammatory signals and mediators
of vascular permeability (15, 16). It has also been hypothesized that infection of
these cell types facilitates the dissemination of filoviruses upon trafficking to
secondary lymph tissues and that cytolytic infection releases virions into the
lymphatics (17).
Little is known about how the bat reservoirs of filoviruses respond either innately or
adaptively to filovirus infection. Antibody responses are generated, showing that
filoviral proteins are recognized, and antigen-presenting cells are enlisted in the
response to infection (9). The roles and responses to infection of myeloid-lineage cells,
such as macrophages and DCs, in rousette bats infected with MARV are unknown but
are surely important for detecting MARV at the sites of infection and orchestrating the
ensuing adaptive immune response. Since ERBs respond to and clear MARV infection
with only mild transient liver pathology (18), we sought to determine the infection
status and host response to MARV infection of ERB myeloid-derived DCs infected in
vitro with a bat isolate of MARV. We found that ERB DCs support low-level MARV
replication and that MARV-infected DCs transcribe steady-state levels of viral RNA
(vRNA). MARV infection induced host gene transcriptional changes in ERB DCs disparate
from what is observed in humans. There was a strong and sustained upregulation of
type I IFN-related antiviral genes. Conversely, DC maturation genes and proinflamma-
tory responses were downregulated upon infection, consistent with a hypothesized
immune tolerance model of MARV infection control by ERBs (19). This response to
MARV infection in specialized innate immune cells of the natural reservoir suggests the
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existence of a coevolved strategy where appropriate antiviral responses are elicited in
combination with inhibition of destructive inflammatory responses and begins to
reveal how ERBs control infection while avoiding disease and while tolerating sufficient
replication for maintenance in the population.
RESULTS
Bone marrow cells differentiate into DCs when exposed to recombinant GM-
CSF/IL-4. We and others have successfully generated cells that have been generally
characterized as bone marrow (BM)-derived dendritic cells (BMDCs) from outbred
animal species, including bats, upon exposure of BM cells to recombinant granulocyte-
macrophage colony-stimulating factor (GM-CSF)/interleukin-4 (IL-4) (20–24). In an at-
tempt to generate BMDCs from ERBs, we isolated BM cells from uninfected ERBs and
cultured them in medium that contained either recombinant human, mouse, or equine
GM-CSF/IL-4 or medium without cytokines. By day 6 in culture, foci of elongated cells
were observed to adhere to the bacterial plates, and conspicuous outgrowth of clusters
of cells in suspension was apparent only in the cultures that contained equine cytokines
(Fig. 1A to D). Control cultures contained only small cells in suspension. Equine
cytokines were chosen due to the similar sequence identity as bat orthologs of these
cytokines (24). At days 8 to 12, high and increasing numbers of cells in suspension were
observed in the cultures containing equine recombinant cytokines, and these cells had
the typical appearance of DCs; the cells were circular, with an increased number of
cytoplasmic projections, and were loosely clustered around sparse adherent stromal
FIG 1 Egyptian rousette bat (ERB) BM cultures generate DCs in response to cytokines. BM from ERBs was
cultured in bacterial petri dishes and fed either medium without cytokines (A and C) or medium
supplemented with equine GM-CSF and IL-4 (B, D, and E). The addition of cytokines stimulated the
outgrowth of clusters of cells after 6 days in culture that were in suspension or loosely adherent and
surrounding adherent cells that resembled monocytes or macrophages. High magnification (D) shows
spherical cells with DC-like morphology.
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cells (Fig. 1E). A yield of approximately 1  107 to 2  107 viable nonadherent DCs was
produced 10 to 12 days after initial seeding of approximately 5  105 BM cells in 10-cm
dishes.
To phenotypically characterize these cells, we performed flow cytometry on cells
harvested 9 days after the initial culture with GM-CSF/IL-4. The forward- and
side-scatter characteristics showed large cells that resembled monocyte-lineage
cells when overlaid with total splenocytes from ERBs run in parallel using identical
protocols and flow cytometer settings (Fig. 2A). We then examined the presence of
cell surface markers indicative of BMDCs using multicolor flow cytometry (Fig. 2B).
Although CD molecule expression patterns might differ between bats and humans
or mice, for which they are well characterized, these molecules are highly conserved
in mammals, and expression patterns on cell subsets are likely similar. The majority
of cells expressed CD11b (approximately 75%), with a subset being double positive
for CD11b and CD14, which is indicative of a monocyte-derived cell population
undergoing differentiation toward DCs, as monocytic DCs express CD11b but are
absent for CD14, and classical and intermediate monocytes are double positive in
humans (25).
MARV replicates to low levels in ERB BMDCs. Since monocyte-lineage cells are
major targets of filovirus infection in humans, we sought to determine whether the ERB
FIG 2 (A) ERB BMDCs express DC markers. BMDC cultures displayed forward-scatter (FSC) and side-scatter (SSC) properties consistent with
DCs or monocytes when overlaid with total splenocytes isolated from ERBs. (B) CD11b was expressed by approximately 75% of cells, and
15% were positive for both CD11b and CD14. Virtually all cells that were CD14 also expressed CD11b.
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BMDCs could support MARV replication. We used a recombinant bat isolate of MARV
(MARV371) that expresses ZsGreen (MARV371-ZsG) to observe the kinetics of MARV371
infection in cultured ERB BMDCs. Cells were infected with MARV371-ZsG at a multiplic-
ity of infection (MOI) of approximately 0.5, as measured on Vero E6 cells, and observed
for 3 days. By 1 day, conspicuous ZsG expression was apparent in 5% of cells (Fig. 3A).
The expression of ZsG increased in intensity as well as in the number of cells out to 3
days, at which time between 10 and 15% of cells showed robust ZsG protein expres-
sion. ZsG expression is indicative of viral gene translation, as ZsG is fused to NP (26) We
then examined the kinetics of replication and transcription of wild-type MARV371
(wt-MARV371) in these cells. DCs were infected with wt-MARV371 at an MOI of 2, and
RNA was extracted from cells and supernatants harvested at 1, 2, and 3 days. Viral RNA
FIG 3 MARV transcription and replication in Egyptian rousette bat BMDCs. Cultures of BMDCs were infected
with MARV371-ZsG (A and B) or wt-MARV371 (B to D). (A) The expression of ZsG over the course of 3 days was
visualized and increased from 5% of cells infected at 1 day, when infected at an MOI of 0.5, to 10% of cells
at 3 days. GFP, green fluorescent protein. (B) Replication was assessed by measuring 3 MARV vRNA targets
incorporated into the NanoString code set. Slight increases in vRNA abundance were observed between 1 and
2 days, and MARV371-ZsG had a similar level of replication at 3 days. Data are represented as the geometric
means and geometric SD from 4 individual bats. (C) TaqMan assays specific for MARV were performed using
total RNA from infected cells and supernatants (SN) and showed slight increases in MARV RNA between 1 and
2 days in the supernatants for all samples. (D) Transcription was measured in these samples using RNA-Seq.
The transcripts were normalized using reads per kilobase of transcripts per million mapped reads to obtain
the transcript abundances of all 7 MARV genes at 3 days. The transcript quantities followed an expected
profile, with high levels of NP and VP40 transcripts, intermediate levels of VP30 and VP24 transcripts, and low
levels of L transcripts.
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levels remained constant over the course of the 3 days in the cells measured using
three different vRNA targets in the NanoString code set (Fig. 3B). Comparison of the
viral RNAs between MARV371-ZsG- and MARV371-infected cells at 3 days showed that
similar but slightly higher levels of wt-MARV371 viral RNA were present, corresponding
to the higher MOI of MARV371, suggesting that MARV371-ZsG and wt-MARV371
replicate similarly (Fig. 3B). Real-time quantitative reverse transcriptase PCR (qRT-PCR)
of cellular RNA and RNA from the supernatant of these cells recapitulated the NanoS-
tring results, with little change in viral RNA levels throughout the time course (Fig. 3C).
To assess MARV371 transcription in BMDCs, deep sequencing (RNA-Seq) was used to
measure transcripts of all 7 viral genes at 1 day. MARV371 infection resulted in an
expected transcriptional gradient, with the most abundant transcripts being the earlier-
transcribed genes (NP, VP40, and GP), indicating active viral transcription within these
cells (Fig. 3D). Taken together, these data demonstrate low but constant levels of
MARV371 replication and transcription in these BMDCs.
MARV induces the transcription of IFN-related genes but inhibits cytokines and
chemokines. In vivo, ERBs are able to largely clear MARV by approximately 2 weeks
after inoculation (8). Presumably, host innate and or adaptive immune responses play
a central role in controlling and clearing these infections while preventing the immune-
mediated pathology observed in humans and in animal models of disease. To deter-
mine how DCs of the natural reservoir respond to MARV infection, we examined the
transcriptional host response to infection in BMDCs between 1 and 3 days following
exposure to wt-MARV371 using NanoString technology and an ERB-specific gene code
set comprised of 380 ERB genes (see Table S1 in the supplemental material) (27). As a
control for gene expression in these cells, lipopolysaccharide (LPS) or Sendai virus (SeV)
was used to stimulate the ERB BMDCs. Treatment with LPS or SeV resulted in the
upregulation of several genes involved in innate immunity and DC maturation (Fig. 4A).
SeV infection resulted in a greater response, with more genes being upregulated and
to a greater level, as well as downregulation of several genes. Infection with MARV371
resulted in an early upregulation of a large set of genes and a strong downregulation
of CXCL2, IL33, OAS1, PDGFRB, and WNT2. By 2 days, many of the genes that were up-
or downregulated at 1 day returned to baseline, whereas other genes, such as EIF2AK2,
IFIT1, IFIT2, ISG15, and OAS3, were upregulated beginning at this time point. By 3 days,
IFI6, IRF7, LGALS9, and USP18 were strongly upregulated. The mRNAs for CCL8, CD80,
IL18R1, LIMK1, and MIP-1A were downregulated only at the 3-day time point. The mRNA
for ICAM1 was downregulated only at 2 days postinfection (dpi) (Fig. 4A). Notably, little
variation was observed between the experimental replicates of 4 BMDC samples, which
were derived from 4 different ERBs (Fig. 4B). Although cells derived from bat 2 showed
the greatest gene regulation (up or down) in most cases, the trend of regulation was
the same for all bats when genes were regulated to approximately 10-fold and
oftentimes even below 10-fold.
MARV upregulates antiviral pathways and inhibits proinflammatory and mat-
uration pathways in BMDCs. We used Ingenuity Pathway Analysis (IPA) to predict the
upstream pathways, relative to those seen in humans, that result in the gene expression
profile that we observed as well as the downstream pathways that are either activated,
inhibited, or dysregulated. To examine if ERB BMDCs respond in a similar manner to
BMDCs from other species, we examined the effect on signaling pathways upon
exposure to LPS or infection by SeV. Exposure to LPS resulted in the positive upregu-
lation of several pathways involving pattern recognition receptors (PRRs), NF-B sig-
naling, and DC maturation, as expected in the case of LPS stimulation of DCs (Fig. 5A).
Pathways upregulated as a result of SeV infection included IFN signaling, DC matura-
tion, and the activation of IFN regulatory factors (IRFs). Genes for pattern recognition
receptors involved in recognition and neuroinflammation signaling were downregu-
lated, whereas signaling involving innate-adaptive immune responses was dysregu-
lated, with some genes involved in these pathways having positive effects and others
having a negative effect (Fig. 5B).
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We then assessed the pathways resulting in the gene expression changes to
MARV371 infection in BMDCs and found that IPA-predicted upstream regulators that
are positively activated at 1 day include several genes involved in innate and adaptive
immune responses (Fig. 5C). At 1 day, only the IL-10 upstream regulator was strongly
inhibited. By 2 days, IFN- and IFN- poly(I·C)-RNA pathways were still positively
regulated; however, Toll-like receptor 3 (TLR3) and LPS pathways were inhibited. By 3
days, only the TLR3 upstream predicted pathway was inhibited. IPA was then used
to determine the downstream pathways that were significantly regulated in re-
sponse to MARV infection (Fig. 5D). The Th1 and Th2 activation pathways, IL-12
signaling and production, glucocorticoid receptor signaling, the IL-15 pathway, and
rheumatoid arthritis pathways were all strongly and significantly dysregulated at 1
day. By 2 days, most immune-related pathways were dysregulated, with the excep-
tion of DC maturation, which was strongly downregulated. At 3 dpi, IFN signaling
pathways were strongly upregulated, as was the related IRF activation by the PRR
pathway; however, the NF-B signaling pathway was downregulated. The IFN
signaling pathway was activated to the highest degree at 3 days, suggesting a
strong antiviral response to MARV infection. The most inhibited pathway through-
FIG 4 Host transcriptional responses to MARV in ERB BMDCs. Total RNA was extracted from 4 cultures of BMDCs infected with wt-MARV371 at an MOI of 2
and used to quantitate the expression of 380 ERB-specific genes using NanoString. Cultures treated with LPS or infected with Sendai virus (SeV) were harvested
at 1 day. Significant changes in gene expression that meet the requirements of a P value of 0.05, 1.5-fold up- or downregulation, and 2 times the standard
deviation of the uninfected controls are shown. (A) Heat map showing the genes that meet these requirements under any of the conditions (LPS, SeV, or MARV)
at any time point. (B) Selected genes for visualization of the individual BMDC samples over time.
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FIG 5 MARV activates antiviral responses and inhibits maturation and inflammatory responses in Egyptian rousette bat BMDCs. Ingenuity Pathway Analysis
(IPA) was performed using the gene regulation data. (A and B) The top 10 pathways and their upregulation (red boxes), downregulation (blue boxes), or
dysregulation (black boxes) for LPS (A) and SeV (B) at 1 day posttreatment. The Z-score indicates the strength of activation or inhibition of a pathway. (C and
D) The top 10 upstream predicted regulators of the observed gene expression profiles in response to MARV371 infection at 1, 2, and 3 days postinfection (C)
and the top 10 canonical downstream pathways at 1 day, 2 days, and 3 days (D). Only significant activation (red boxes), downregulation (blue boxes), and
dysregulation (some genes in the predicted pathway are significantly activated, whereas others are significantly inhibited) (black boxes) are displayed. iNOS,
inducible nitric oxide synthase; MAPK, mitogen-activated protein kinase.
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out the time course of infection was the DC maturation pathway, suggesting that
MARV actively inhibits the maturation of these cells.
DISCUSSION
Little is known about how reservoirs of highly pathogenic zoonotic viruses are able
to immunologically cope with infection by their respective viruses. Furthermore, several
coevolved mechanisms likely exist, and each is host/virus specific. In MARV-infected
ERBs, the viral load is reduced to below detectable levels within a few weeks (28). To
begin to understand how MARV infects and replicates in ERBs without causing overt
disease, we generated BMDCs from ERBs and assessed transcription and replication
kinetics of a bat isolate of MARV, along with the host transcriptional response to MARV
infection. These data provide the first insight into how ERBs immunologically respond
to MARV, namely, by upregulating antiviral pathways to temper replication while
simultaneously downregulating adaptive immune response modulators to prevent
proinflammatory immunopathogenesis.
The methodology used here for generating BMDCs from outbred, nonlaboratory
animals using GM-CSF/IL-4 has been well documented, including for bats (20, 21,
23). Despite not having specific tools for a detailed characterization the DC subtype
generated by the BM of these ERBs, the observation that an outgrowth of cells
morphologically similar to those previously reported and their transcriptional re-
sponses to treatment with LPS and infection with SeV strongly suggest that the
majority of the cells in culture develop into bona fide DCs. This was confirmed using
flow cytometry; the majority of cells expressed CD11b, and a subset of those cells
expressed CD14, indicative of a monocytic cell population transitioning to
monocyte-derived DCs (25).
We show that ERB BMDCs are susceptible to MARV infection and that active viral
transcription is taking place out to 3 days, as evidenced by the transcriptional gradient
measured by RNA-Seq and by ZsG expression of recombinant bat MARV371. Although
human MDDCs infected with EBOV show infection and replication kinetics similar to
what we observe here, with only a small percentage of DCs becoming infected
compared to the MOI used and little replication between 1 and 3 days (29), we detected
lower levels of replication between 1 and 3 days than what was previously reported for
human MDDCs infected with MARV (13). These variations in responses to MARV could
be due to differences in the virus isolates (human versus bat) or cell preparations
(BMDCs versus MDDCs) or, more likely, due to the induction of strong cellular antiviral
responses that we describe in this study, which are uniquely stimulated by MARV
infection in bat DCs.
Upon examining ERB BMDC responses to infection by quantitating host transcrip-
tional responses, two things become apparent: (i) IFN-related genes and pathways with
antiviral properties are significantly upregulated, and (ii) genes and their pathways that
promote DC maturation and adaptive immune responses are significantly downregu-
lated or dysregulated. When we investigated ERB BMDC responses to infection, we
found strong transcriptional induction of IFN-related antiviral responses, including the
upregulation of STAT1 by 1 day; PKR, IFIT1, IFIT2, ISG15, and OAS3 by 2 days; and IFI6 and
IRF7 at 3 days. This is in marked contrast to the transcriptional responses measured in
human DCs infected with EBOV in vitro, where genes of the innate immune responses
are not induced and are antagonized by VP35, with only a modest upregulation of
IFNb1 (30). IPA shows that the ERB BMDCs respond by a significant upregulation of IFN
signaling, and the upstream predictors of the gene expression profile observed are
primarily type I IFN and IFN-related transcription factors that are associated with
antiviral responses. This unique activation might directly relate to the expansion and
diversification of ERB immune genes that were recently hypothesized to be a mecha-
nism of tolerance to viral infection by these bats (19).
While some information exists as to the transcriptional responses to EBOV in
relevant cell types, there is a paucity of information for responses to MARV in vitro. In
MARV-infected nonhuman primates (NHPs), many chemokine and cytokine genes were
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upregulated at early time points in peripheral blood mononuclear cells (PBMCs), in line
with the model that viral proteins antagonize IFN, thereby allowing for uncontrolled
viral replication and a subsequent cytokine storm (31). Although the responses in NHPs
were measured in PBMCs, the early time points of gene upregulation indicate that cells
possessing innate sensors of infection, such as macrophages and DCs, are responsible
for gene regulation. In ERB BMDCs, cytokine and chemokine genes were either not
regulated or significantly downregulated, as in the case of CCL8, which encodes a
chemokine that recruits leukocytes to sites of infection (32). The transcription of CCL8
was strongly upregulated throughout the course of disease in NHPs infected with
MARV, starting as early as 1 dpi (31). In response to infection with EBOV, NHPs with fatal
infections upregulate CCL8 beginning at 4 dpi (33). Similar to CCL8, CXCL2 encodes a
chemokine that is proinflammatory (32) and is upregulated in mice that succumb to
EBOV infection (34) but downregulated here in ERB BMDCs. We observe that mRNAs of
DC activation and costimulatory molecules are either not induced, such as CD40, or
downregulated, such as CD80. In human cells infected with either MARV or EBOV,
protein levels of the costimulatory molecules CD40 and CD80 were similarly not
induced (13, 29). Here, IPA showed a significant downregulation of DC maturation and
NF-B signaling, whereas several other pathways related to adaptive immune re-
sponses, such as the Th1 and Th2 pathways, and communication between innate and
adaptive immune cells are significantly dysregulated.
The most strongly downregulated gene was IL33, which was downregulated at all
time points in MARV371-infected ERB BMDCs. Mechanistically, IL-33 acts as an alarmin
that is stored in the nucleus of several cell types and potentiates Th2 inflammatory and
antibody responses upon release. IL-33 also promotes DC development from BM (35).
IL-33 is centrally important in dengue virus infection and is strongly upregulated in
mice that develop disease. The addition of recombinant exogenous IL-33 in dengue
virus-infected mice resulted in severe disease with proinflammatory cytokine produc-
tion and liver damage; thus, neutralization of IL-33 has been proposed as a target for
therapeutics (36). The release of IL-33 is also important for responses to malaria and
hepatotropic viruses, where high levels of IL-33 correlate with hepatic damage in
humans (37). The downregulation of IL33 in infected ERB BMDCs may be a coevolved
response to limit proinflammatory responses. It may also relate to the observation that
ERBs generate relatively weak and short-lived antibody responses to MARV infection,
with IgG levels waning to undetectable levels by 3 months postinfection (8). In NHPs
infected with MARV, nuclear IL-33 protein was lost in high endothelial venules and
fibroblastic reticular cells of the lymph node, despite being absent for MARV antigen,
suggesting that the protein is released as an alarmin and might act to promote the
uncontrolled inflammatory responses that potentiate disease in NHPs (38). It will be
important to assess the consequences of IL33 downregulation in other cells and in
tissues of infected ERBs, as this protein may be important for the balance that ERBs
have achieved between inhibiting the production of antibodies and Th2 responses and
limiting cytokine-induced pathology.
Conversely, the mRNA for Galectin-9 (LGALS9) was strongly upregulated at 3 dpi,
and the Th1 and Th2 pathways were perturbed at all 3 time points by MARV
infection. LGALS9 promotes and stabilizes inducible regulatory T cells (iTregs) (39).
In DCs, LGALS9 is important for pathogen uptake and is indispensable for phago-
cytosis (40). Treg responses in the natural reservoirs of viral hemorrhagic fevers
(VHFs) have been observed previously, as the rodent reservoirs of hantaviruses
avoid immunopathology by the upregulation of Tregs to actively counteract in-
flammatory responses (41, 42).
Antagonism of the innate immune response has emerged as an important contrib-
utor to pathogenesis for many viruses, including pathogenic filoviruses. The VP35 and
VP40 proteins of MARV possess several strategies to antagonize or otherwise subvert
interferon-related innate immune responses upon infection of cells of certain species
(14, 43). Presumably, these viruses have evolved this ability within the natural reservoir
hosts, as infections of humans are thought to primarily be dead-end events. What is
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unknown is the specific roles that antagonism plays in the reservoir hosts and why
inhibition of IFN responses is not detrimental to the host. IFN antagonism likely
regulates the balance between effective innate immune responses that control virus
replication and prevent inflammatory-related disease, as in the case of ERBs, and
uncontrolled MARV replication that would result in immunopathogenesis, perhaps in a
cell type-specific manner. In contrast to the responses in BMDCs presented here, where
we see a strong upregulation of upstream and downstream IFN signaling pathways, our
group recently investigated the transcriptional responses to MARV in a kidney-derived
cell line from ERBs. Despite the much higher level of MARV replication in the kidney cell
line than in the BMDCs, or perhaps as a result of it, almost no IFN-related antiviral gene
regulation was measured, similar to what is observed in humans and disease models.
The lack of IFN-related responses in ERB kidney cells was due to the interferon-
antagonistic activities of VP35 (27).
The results presented here begin to elucidate how innate immune cells of coevolved
hosts manage filovirus infection and show that the responses to MARV infection/
replication differ between bats and dead-end hosts and even differ between cell types
of the same host. Where MARV inhibits antiviral IFN-related responses in human cells
universally (specialized innate immune cells and non-innate immune cells) and in
non-innate immune cells in the ERB host, these antiviral responses are uniquely
induced in ERB DCs. The ability of ERB DCs to overcome MARV-directed antagonism of
antiviral responses is likely a coevolved and essential strategy directed toward the
controlled elimination of MARV and diminished DC-mediated dissemination, while
MARV simultaneously antagonizes IFN responses in nonimmune cells to a level that
allows for sufficient replication for transmission and maintenance in the natural reser-
voir.
MATERIALS AND METHODS
Biosafety. Work with infectious agents and infected animals was conducted at the CDC (Atlanta, GA,
USA) in a biological safety level 4 (BSL-4) laboratory in agreement with Select Agent protocols and
practices (www.selectagents.gov). Researchers and animal care staff worked in accordance with BSL-4
level safety principles and adhered to proper infection control procedures.
Ethics statement. Work with ERBs was approved by the Institutional Animal Care and Use Commit-
tee (IACUC) of the CDC. The CDC is accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC).
Isolation of bone marrow and generation of bone marrow-derived dendritic cells. Bone marrow
(BM) was obtained from captive ERBs of Ugandan origin (28) that were euthanized for unrelated studies
at the CDC. The animals were adult males. The radii and humeri were excised and then cleaned of tissue.
Following the removal of the epiphyses and cutting of the radii in half, the BM was flushed out of the
bones using 5 ml of cold Hanks’ balanced salt solution (HBSS) and 20-gauge blunt-ended syringes and
collected in a 15-ml tube containing 5 ml of ice-cold HBSS. The BM was then triturated to break up
clumps, centrifuged at 350  g for 7 min, and gently resuspended in the residual HBSS after pouring off
the supernatant. The cells were then enumerated and either cryopreserved in 90% fetal bovine serum
(FBS)–10% dimethyl sulfoxide (DMSO) (1  107 to 2  107 cells/ml) or used directly for cultures.
For the generation of DCs, BM cells were washed in RPMI 1640 containing 10% FBS, HEPES, and
antibiotics (complete RPMI medium), and approximately 2  106 cells were plated in 10-cm bacterial
(non-tissue-culture-treated) petri dishes containing 10 ml of prewarmed complete RPMI medium or
complete medium supplemented with recombinant cytokines (RPMIC). Cytokines used were a com-
bination of either human, mouse (both from R&D Biosystems), or equine (Kingfisher Bio) GM-CSF and IL-4
at 25 mg/ml each. After incubation for 3 days (37°C in 5% CO2), an additional 10 ml of complete RPMIC
was added, and at 6 days, 10 ml of medium was gently pipetted off the petri dishes and replaced with
fresh prewarmed complete RPMIC. This was repeated on day 8 and every 2 days thereafter until the
cells were harvested for use in experiments. Cells were harvested 1 to 2 days after conspicuous growth
was observed, typically between days 10 and 12. For harvesting, the petri dishes were gently rinsed in
medium to remove the nonadherent and loosely adherent cells. These cells were washed once in RPMI
medium and then resuspended in complete RPMIC for plating in 48-well tissue culture plates (5  105
cells) or retained in 15-ml tubes for infections prior to plating.
Infection of BMDCs. Cells that were freshly harvested and enumerated were resuspended in a
minimal volume of RPMI medium and incubated with either MARV (isolate Uganda 200704852 Uganda
Bat, termed MARV371) at an MOI of 2 or the bat isolate of MARV371 expressing ZsGreen (MARV371-ZsG)
at an MOI of 0.5 (26) for 1 h at 37°C with 5% CO2, with periodic gentle mixing. Cells were then washed,
and 5  105 cells were plated in 24-well plates in complete RPMIC. At the indicated time points, cells
and supernatants were harvested and used for experiments. For Sendai virus infection, 30 hemaggluti-
nation (HA) units (MOI  1) of the Cantell strain were added directly to the cells in 48-well plates. Cells
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infected with MARV-ZsG were visualized and images were captured using an Evos cell imaging system
(Thermo Fisher).
Flow cytometry. DCs were harvested from bacterial petri dishes by gently rinsing and collecting the
nonadherent cells and washed in Dulbecco’s phosphate-buffered saline (DPBS) prior to staining for
viability with Live/Dead Aqua viability dye (Invitrogen). Cells were then washed in PBS containing 2% rat
serum before incubation with a custom rat anti-Rousettus aegyptiacus CD14-phycoerythrin (PE) antibody
and an anti-human/mouse CD11b-allophycocyanin (APC)/Fire 750 antibody (BioLegend). The cells were
then washed and fixed in Cytofix/Cytoperm (BD Biosciences) overnight and washed again in PBS
containing 2% rat serum, flow cytometry was performed using a Stratedigm custom cytometer (Strat-
edigm, Inc.), and data were analyzed using FlowJo software, version 10 (TreeStar).
RNA isolation and quantitative reverse transcriptase PCR. DCs were harvested using MagMAX
RNA lysis/binding solution concentrate (Thermo Fisher Scientific), and RNA was extracted by magnetic
bead purification using the MagMAX-96 DNA/RNA pathogen kit run in a MagMAX Express-96 magnetic
particle processor (Thermo Fisher Scientific). qRT-PCR was conducted using the SuperScript III Platinum
one-step qRT-PCR kit (Thermo Fisher), using TaqMan-based probes against MARV VP40.
Gene expression measured by NanoString. A custom NanoString nCounter ERB-specific code set
targeting 380 ERB and 10 MARV genes was designed by NanoString Technologies using the Raegyp2.0
genome assembly (RefSeq accession number GCF_001466805.2) and NCBI R. aegyptiacus annotation
release 100, expanded from a previous code set that consisted of 221 genes (see Table S1 in the
supplemental material) (27). Hybridization reactions were performed according to the manufacturer’s
instructions, as previously described (27). Briefly, hybridization buffer was mixed with the reporter code
set reagent, aliquoted into PCR tubes, and then mixed with total RNA from DCs and finally with the
Capture ProbeSet reagent. Samples were pulse spun and incubated for 24 h at 65°C. Sample sets were
then loaded onto an nCounter cartridge and run in an nCounter Sprint profiler for count data collection.
nCounter transcriptomic analysis. nCounter data were processed using nSolver 4.0 software
(NanoString). After quality control of RCC files, raw counts across all samples were normalized, without
background subtraction or thresholding, to the geometric mean counts of synthetic positive controls
included in hybridization reactions. The top five most stable genes in each tissue data set were selected
as reference genes using the geNorm algorithm within the nCounter Advanced Analysis (nCAA) module
(version 2.0.115). For each sample, normalization was performed by dividing counts for each gene by the
geometric mean of the five reference genes. nCAA was used to calculate differential gene expression
(DGE) of each data set. Significance, relevance, and count threshold criteria used for DGE analysis at each
time point were set to a minimum of a 1.5-fold change (FC), a Benjamini-Yekutieli-adjusted P value of
0.05 (44), and an above-background count threshold of 2 times the standard deviation (SD) of the
mean counts of all synthetic negative controls across all samples. In order to be considered a bona fide
differentially expressed gene (DEG) in any given data set, all three criteria were required for at least one
time point value.
RNA-Seq data collection and analysis. RNA was evaluated for quality on the Agilent 2200
TapeStation. Libraries were generated on the Sciclone G3 liquid-handling robot (PerkinElmer) using the
TruSeq stranded total RNA library prep kit (Illumina). Library quality was assessed on the TapeStation and
quantitative PCR (qPCR) quantitated using the Kapa complete (universal) qPCR kit (Kapa Biosystems) for
Illumina. Libraries were diluted to 12 pM, cluster generation was performed on the Illumina cBot, and
sequencing was performed on the HiSeq 2500 system using the paired-end 2- by 125-bp, dual-index
format. Raw reads were first verified by FastQC and then trimmed for low-quality reads/adapters and
filtered using Trimmomatic-0.33. Analyses of next-generation sequencing (NGS) data, including read
mapping and variant detection, were done using CLC Genomics Workbench 9.1.
Pathway analysis. Ingenuity Pathway Analysis (IPA; Qiagen Bioinformatics) was used to determine
significantly enriched pathways and upstream regulators for each tissue data set.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00728-19.
TABLE S1, PDF file, 0.1 MB.
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